GSK
GSK·NYSE
--
--(--)
--
--(--)
GSK Filings
Filing Date
Form Description
Form Type
2026-03-25
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-25 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-25
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-25 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-24
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-24 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-23
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-23 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-23
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-23 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-23
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-23 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-23
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-23 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-20
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-20 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-19
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-19 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-03-19
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-03-19 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
